Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients (Cochrane Review)

How we can help you
To learn more about Update Software and how we can provide solutions for your data management and web & CD publication needs visit our home page.

Useful resources
The Reproductive Health Library: the best evidence in sexual and reproductive health.
Evidence-based Health Care Workbook and CD-ROM

New abstracts this issue

Search abstracts

Alphabetical list of abstracts

Abstracts by Review Group

Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients (Cochrane Review)
Hankey GJ, Sudlow CLM, Dunbabin DW

ABSTRACT

Background: The most widely studied and prescribed antiplatelet agent for the prevention of stroke and other serious vascular events among high vascular risk patients is aspirin. Aspirin inhibits platelet activation by inhibiting platelet cyclooxygenase and thro . . .

Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com
Resources: WHO Reproductive Health Library, La Biblioteca Cochrane Plus, Renal Health Library, Malaria in Pregnancy Library
PubMed: Find related PubMed articles here [HankeyGJ] [SudlowCLM] [DunbabinDW]
Google Scholar: Find related Google Scholar articles here [HankeyGJ] [SudlowCLM] [DunbabinDW]